
Homeplus' recovery falters as sales slump, buyer search stalls
view more
DaouKiwoom-CJ consortium picked as preferred bidder for debt-laden JoongAng Ilbo
view more
Academics explore how entrepreneurs can navigate AI disruption at Jinju forum
view more
Musinsa, Sono International face IPO uncertainty amid market volatility
view more
Can North Jeolla Province become Korea's 3rd financial hub?
view more
Hyundai Motor, Kia to launch Level 4 autonomous truck trials
view moreYOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
Samsung Bioepis secures 10-year exclusive drug supply deal in Brazil
Samsung Bioepis has secured a decade-long exclusive supply deal for a rare disease treatment in Brazil, strengthening its position in Latin America’s largest pharmaceutical market while opening a new chapter in its partnership with the Brazilian government. The Korean biopharmaceutical company said Tuesday it had signed a local partnership agreement to supply SB12, a biosimilar of Soliris with the active ingredient eculizumab, to Brazil’s Ministry of Health. SB12 is used to treat rare conditions including paroxysmal nocturnal hemoglobinuria, a blood disorder, and atypical hemolytic uremic syndrome, which can damage blood cells, kidneys and other organs. Brazil’s health regulator, the National Health Surveillance Agency, known as ANVISA, approved the drug in December 2024. The Brazilian eculizumab market was worth about $170 million (250 billion won) last year, according to the company, which expects the 10-year exclusive supply agreement to provide a stable source of revenue. Under the government-led Productive Development Partnership program, Samsung Bioepis will work with Brazilia
GS Global invests in carbon credit firm to expand trading business
GS Global is expanding into carbon credit trading through an equity investment in Hooxi Partners, a Korean carbon credit specialist, seeking to monetize emissions reductions from its existing eco-friendly businesses. GS Global said Tuesday that the investment would establish a strategic partnership, combining Hooxi Partners’ carbon reduction expertise with GS Global’s global network and trading capabilities. The investment comes as Korea's fourth emissions trading scheme, covering 2026-2030, takes effect. Tighter emissions caps, expanded paid allocations and stricter global carbon regulations are raising the cost of securing carbon credits and increasing exposure to price volatility. GS Global aims to turn carbon credits into a new growth engine. Founded in 2021, Hooxi Partners offers services ranging from carbon credit methodology development and emissions reduction project management to securing Korean Offset Credits (KOCs) and forward trading. The company focuses on transportation-related emissions reduction projects, particularly the transition to electric vehicles. It also oper
K-beauty expo to open this week in Cheongju
North Chungcheong Province said Tuesday it will hold its annual cosmetics and beauty expo in Cheongju to help Korean companies expand exports of cosmetics and other beauty products. The Cosmetics & Beauty Expo Osong Korea 2026 will run from Thursday to Saturday in Osong, a district of Cheongju, 83 kilometers south of Seoul. The event aims to connect local companies with international buyers, according to the provincial government. More than 250 companies are expected to participate in the business-to-business (B2B)-focused event, which is being held under the theme "K-Beauty Osong seeks growth along with global partners." "This year's expo, the largest edition to date, will provide local companies with opportunities to expand into overseas markets and allow visitors to experience K-beauty products," Jang Woo-sung, director general of the provincial government's bureau of biologics, food and drugs, said. The expo has been held annually in Cheongju since 2013, except in 2014. The provincial government has partnered with the Korea Trade-Investment Promotion Agency (KOTRA) to invite 200 domes
Hyundai Motor, Kia to test Level 4 autonomous trucks
Hyundai Motor and its sister company Kia said Tuesday they will conduct test operations of Level 4 autonomous trucks as part of an ongoing effort to advance self-driving technology and pave the way for commercialization. The automakers signed a memorandum of understanding (MOU) for the project with Hyundai Motor Group affiliates Hyundai Mobis Co. and Hyundai Glovis Co., as well as autonomous driving technology startups Mars Auto and RideFlux, at the group's Namyang R&D Center in Hwaseong, southwest of Seoul. Level 4 autonomous driving allows vehicles to operate without human intervention, including in emergency situations, under specified conditions and within designated operational areas. According to the MOU, Hyundai Motor and Kia will develop and supply two Xcient trucks, including a hydrogen fuel cell model, early next year. The test program will cover approximately 500 kilometers across two routes: a 100-kilometer section combining highways and urban roads, and a 400-kilometer long-distance highway route.
Bị AI phỏng vấn quá nhiều, chàng trai quyết định cử AI của mình trả lời: 6 phút tuyển dụng hỗn loạn
Đoạn video do Graham đăng tải cho người dùng thấy một tương lai việc làm khác trong kỷ nguyên AI, thậm chí có bình luận còn tự hỏi: chúng ta đang xây dựng kiểu tương lai gì vậy?
Tưởng mua Ryzen cao cấp, khách hàng nhận CPU Intel cũ “đè tem” AMD
Một chiếc CPU nằm trong hộp nguyên seal, được chính Amazon bán và vận chuyển, vẫn khiến người mua nghi ngờ ngay khi lật mặt dưới: lớp vỏ mang tên Ryzen cao cấp nhưng phần tiếp xúc lại giống một bộ xử lý Intel cũ.









